Urge your members of Congress to support continued medical research funding
ASH is the leader in representing the interests of scientists and clinicians working in the field of hematology on Capitol Hill and within federal agencies concerned with the study and treatment of blood-related diseases.
A multi-faceted initiative to identify the highest priority actions needed to improve the outcomes for individuals with SCD in the U.S. and globally.
Urge your members of Congress to support continued medial research funding.
Provides opportunities to learn more about advocacy, health policy, and the legislative process, and to become engaged in the Society’s activities.
Provides education about the policy making process, including Congress’ relationship to the hematology community.
Get an overview of the Medicare Access and CHIP Reauthorization Act (MACRA) and its impact on hematology.
Keep informed of newly approved therapies, safety and prescription matters, and shortages of critical hematologic drugs.
Learn about the yearly ASH-ASCO Carrier Advisory Committee (CAC) Network Meeting.
ASH is joining Rearch!America and other public health organizations to participate in Public Health Thank You Day to recognize public health professionals who work tirelessly every day to protect us from disease, injury, and other health threats. As part of the day, ASH encourages Grassroots Network members and hematologists across the country to thank Congress for supporting America’s public health programs
Over the past several months, ASH has met with congressional offices and called on members of the ASH Grassroots Network to take action in support of increased funding for the National Institutes of Health (NIH). Because of your efforts and the work of medical research advocates across the country, Congress passed final fiscal year (FY) 2019 appropriations legislation in late September that included a $2 billion dollar increase to the NIH for a total funding level of $39.1 billion, a 5.4% funding boost over FY 2018 levels. President Trump signed the funding bill into law on September 28.
2018 was full of federal policies and proposals related to
access to care and drug pricing. The Administration made more changes to the
Affordable Care Act and highlighted that drug pricing is a priority.
CMS released a National Coverage Determination entitled Next Generation Sequencing for Medicare Beneficiaries with Advanced Cancer. ASH submitted comments on the proposal along with over 300 other groups, including physician specialty societies, patient advocacy groups, and industry groups.
Senators Tim Scott (R-SC) and Cory Booker (D-NJ) introduced the Sickle Cell Disease Surveillance, Prevention, and Treatment Act of 2018.
On December 20, the House of Representatives and the Senate voted to approve H.R. 1, tax reform legislation. Select members of each chamber came together to resolve disagreements between the two versions passed by the House and Senate.
Join the Grassroots Network to stay up to date on all of ASH’s Advocacy Campaigns.
Become an advocate for hematology with our easy-to-use advocacy resources.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology